Released May 15, 2014, after the close
10-Q filed May 15, 2014, 45 days after period end · 0000926617-14-000033
Q1 2014 · 10-Q
Revenue$305.00K$305.00K −7.0% vs Q1 2013−80.8% vs Q4 2013
Net Income-$3.99M-$3.99M N/M vs Q1 2013N/M vs Q4 2013
EPS Diluted-$0.11-$0.11 N/M vs Q1 2013no prior Q4 2013 on file
Gross Profit$250,000−14.1%
Operating Income-$3,995,000N/M
Operating Cash Flow-$3,505,000N/M
Free Cash Flowderived-$3,524,000—
Margins · derived
Gross margin82.0%−6.8 pt vs Q1 2013
Operating margin-1309.8%−516.5 pt vs Q1 2013
Net margin-1307.2%−523.4 pt vs Q1 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $305.00K | $328.00K | $312.00K | $431.00K |
| Net Income | -$3.99M | -$2.57M | -$1.78M | -$4.29M |
| EPS Diluted | -$0.11 | -$0.17 | -$0.12 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR